title: Decreased susceptibility of glycated very low density lipoproteins to lipoprotein lipase in vitro and prevention by glutathione.
abstract: In vitro glycation of very low density lipoprotein (VLDL) reduced the susceptibility to lipoprotein lipase (LPL) as the level of glycation increased. Addition of reduced glutathione to an incubation medium of serum and glucose interfered with glycation of serum proteins when the concentration of reduced glutathione was higher than 10 mM. At concentrations higher than 25 mM, it also significantly prevented the glycation induced reduction of fatty acid releases from VLDL by LPL. There were no such effects on glycation of serum protein and the fatty acid release from the addition of aminoguanidine. By contrast, addition of D-lysine enhanced glycation of serum proteins by glucose and further decreased fatty acid release from VLDL by LPL. From these results, it is suggested that glycation of VLDL decreases the susceptibility of VLDL to LPL. Delayed catabolism of VLDL in diabetic patients is considered partly caused by glycation of apoproteins, which renders VLDL less sensitive to LPL, in addition to the decreased LPL activity in diabetes mellitus.
authors.affiliation: Department of Laboratory and Clinical Medicine, Ehime University Medical School, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Saheki
authors.forename: K
authors.initials: K
authors.lastname: Shishino
authors.forename: Y
authors.initials: Y
authors.lastname: Hitsumoto
authors.forename: M
authors.initials: M
authors.lastname: Murase
authors.forename: N
authors.initials: N
authors.lastname: Takeuchi
authors.forename: K
authors.initials: K
authors.lastname: Uchida
mesh_terms: D002384:Catalysis; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005227:Fatty Acids / Q000378:metabolism; D005978:Glutathione / Q000494:pharmacology*; D006031:Glycosylation; D006146:Guanidines / Q000494:pharmacology; D006801:Humans; D006868:Hydrolysis; D008071:Lipoprotein Lipase / Q000037:antagonists & inhibitors*; D008079:Lipoproteins, VLDL / Q000378:metabolism*; D008239:Lysine / Q000494:pharmacology; D010084:Oxidation-Reduction; D013237:Stereoisomerism; D013379:Substrate Specificity
chemical_list: D004791:Enzyme Inhibitors; D005227:Fatty Acids; D006146:Guanidines; D008079:Lipoproteins, VLDL; D008071:Lipoprotein Lipase; D005978:Glutathione; D008239:Lysine; C004479:pimagedine